Barclays Turned Bearish on NuScale Power at a 52-Week Low. Here's the Single Missing Contract That Would Prove It Wrong.

NuScale Power's stock has declined 85% from its 52-week high, prompting Barclays to reduce its price target from $11 to $5. The company has achieved regulatory approval for its small modular nuclear reactor design but lacks a signed customer contract, which is critical to validate its business model. NuScale is burning through cash while awaiting potential deals with RoPower in Romania and ENTRA1 Energy in the U.S., with negotiations expected to extend into early 2027.